On the stock market since 2022, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 54% below its peak. The market has trimmed its expectations for the company.
Sales run at $62.9M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 4 buys and 1 sell. Management buying with its own money is usually read as a good sign.
A loss of $8.7M against $62.9M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, ATAK sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ATAK is a high-risk stock — not yet profitable, and its future rides on its product catching on.